18th COGNO Annual Scientific Meeting
Welcome to the 2026 COGNO Annual Scientific Meeting. In a significant partnership with the Neurosurgical Society of Australasia (NSA), we gather in Adelaide for the first time this year to […]
SNO/ASCO CNS Metastases Conference
The Society for Neuro-Oncology (SNO), in collaboration with the American Society of Clinical Oncology (ASCO), present this year’s SNO/ASCO CNS Metastases Conference to be held August 13-15, 2026, at the […]
7th Global Cancer Summit
After the grand success of Global Cancer Summit – 2015 in Bengaluru, India and 2nd Global Cancer Summit 2017 in Kuala Lumpur, Malaysia, 3rd Global Cancer Summit 2019, Dubai, United […]
Cancer Genomics Consortium (CGC) 2026 Annual Meeting
The CGC 2026 Annual Meeting will kick off this year with the Unconference on Saturday afternoon and Sunday Morning. The scientific agenda will start on Sunday afternoon and run through […]
ESMO Immuno-Oncology & Advanced Therapies Congress 2026
Join us at the ESMO Immuno-Oncology & Advanced Therapies Congress 2026, which will take place from 14 to 16 December 2026, onsite in London, United Kingdom, and online. A leading […]
ESMO Asia Congress 2026
We are delighted to welcome you to the ESMO Asia Congress 2026 in Singapore, from 4 to 6 December 2026. This premier meeting will bring together oncology professionals from across […]
ESMO AI and Digital Oncology Congress 2026
The ESMO AI & Digital Oncology Congress is a central meeting point for the latest research, ethical dialogue, and technological innovation in cancer care. Bringing together healthcare and digital health […]
Molecular Analysis for Precision Oncology Congress 2026
The Molecular Analysis for Precision Oncology Congress 2026 will take place from 10 to 11 September in London, UK, bringing together leading experts in oncology, molecular diagnostics, and precision medicine […]
Addenbrooke’s innovation expands access to advanced genome testing for cancer patients nationally
A service pioneered at Addenbrooke’s Hospital that could help up to three times more cancer patients benefit from whole genome sequencing (WGS) has won a national award and been accredited […]
Clatterbridge research team given £475,000 grant to expand landmark research
A research team working with The Clatterbridge Cancer Centre has been awarded more than £475,000 from Blood Cancer UK to continue and expand UNCOVER, one of the largest blood cancer […]
